Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)
China · Delayed Price · Currency is CNY 5.15
+0.11 (2.18%)
At close: Jul 31, 2026
SHE:300511 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 195.72 | 29.79 | -617.07 | -188.06 | -287.23 | -311.59 |
Depreciation & Amortization | 337.64 | 337.64 | 373.92 | 324.76 | 341.34 | 314.26 |
Other Amortization | 2.9 | 2.9 | 5.13 | 9.75 | 8.97 | 9.97 |
Loss (Gain) From Sale of Assets | -16.31 | -16.31 | -7.85 | 6.46 | 8.42 | 18.4 |
Asset Writedown & Restructuring Costs | 1.23 | 1.23 | 377.71 | 62.46 | 402.89 | 194.12 |
Loss (Gain) From Sale of Investments | -1.05 | -1.05 | 0.65 | 2.65 | -8.87 | -1.01 |
Provision & Write-off of Bad Debts | 0.71 | 0.71 | 6.01 | - | - | - |
Other Operating Activities | 37.09 | 85.5 | 142.75 | 83.21 | -17.7 | 43.66 |
Change in Accounts Receivable | -18.16 | -18.16 | 11.8 | 4.74 | 11.16 | -6.06 |
Change in Inventory | -61.42 | -61.42 | 73.99 | -58.19 | -89.3 | -57.64 |
Change in Accounts Payable | 55.01 | 55.01 | 70.16 | 115.93 | 9.04 | 43.3 |
Change in Other Net Operating Assets | - | - | - | -5.87 | -24.41 | 1.67 |
Operating Cash Flow | 533.37 | 415.85 | 437.2 | 357.84 | 367.13 | 244.06 |
Operating Cash Flow Growth | 20.22% | -4.88% | 22.18% | -2.53% | 50.43% | -56.06% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -131.02 | -79.59 | -327.46 | -1,097 | -319.47 | -637.19 |
Sale of Property, Plant & Equipment | 24.51 | 25.59 | 18.13 | 69.23 | 88.28 | 60.6 |
Divestitures | - | - | - | - | 78 | - |
Investment in Securities | - | 4.6 | - | 271.05 | -272 | -20 |
Other Investing Activities | - | - | - | 1.51 | 1.99 | 1.89 |
Investing Cash Flow | -106.51 | -49.4 | -309.33 | -755.24 | -423.21 | -594.7 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 80 | 18 | - | 11.52 | 3.89 |
Long-Term Debt Issued | - | 453.81 | 1,165 | 1,201 | 910.94 | 927.61 |
Total Debt Issued | 624.27 | 533.81 | 1,183 | 1,201 | 922.46 | 931.49 |
Short-Term Debt Repaid | - | -33.76 | -3.18 | - | - | - |
Long-Term Debt Repaid | - | -781.12 | -1,242 | -902.45 | -1,207 | -914.41 |
Total Debt Repaid | -640.1 | -814.87 | -1,245 | -902.45 | -1,207 | -914.41 |
Net Debt Issued (Repaid) | -15.83 | -281.06 | -61.49 | 299 | -284.12 | 17.09 |
Issuance of Common Stock | - | - | 8.11 | - | 386.73 | - |
Repurchase of Common Stock | -30.41 | -30.41 | -28 | -13.92 | -20.2 | -1.74 |
Common Dividends Paid | -39.63 | -42.68 | -67.01 | -60.32 | -58.73 | -102.59 |
Other Financing Activities | -97.9 | -3.36 | 11.96 | -20.1 | 43.42 | 18.75 |
Financing Cash Flow | -183.78 | -357.51 | -136.42 | 204.65 | 67.1 | -68.5 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -0.8 | 0.26 | 0.53 | 0.15 | 0.16 | -1.36 |
Net Cash Flow | 242.28 | 9.2 | -8.02 | -192.6 | 11.18 | -420.49 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 402.35 | 336.26 | 109.74 | -739.19 | 47.66 | -393.13 |
Free Cash Flow Growth | 25.66% | 206.40% | - | - | - | - |
Free Cash Flow Margin | 18.08% | 16.92% | 5.08% | -28.82% | 2.05% | -18.96% |
Free Cash Flow Per Share | 0.70 | 0.56 | 0.22 | -1.49 | 0.10 | -0.91 |
Levered Free Cash Flow | 330.42 | 101.81 | -64.78 | -490.08 | -63.88 | -654.65 |
Unlevered Free Cash Flow | 362.29 | 139.73 | -3.4 | -434.6 | -5.78 | -606.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 26.09 | 24.75 | 26.76 | 21.17 | 22.17 | 19.24 |
Change in Working Capital | -24.57 | -24.57 | 155.95 | 56.61 | -80.69 | -23.75 |